GRP
SLN

Global Retirement Partners’s Silence Therapeutics SLN Stock Holding History

Global Retirement Partners’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.08K Buy
+1,000
New +$6.4K ﹤0.01% 3368

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Global Retirement Partners's SLN Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Silence Therapeutics (SLN) in Q4 2025: 1,000 shares worth $6.08K. The stake represents ﹤0.01% of the portfolio and ranks #3368 among its holdings.

58 funds tracked by Wall St. Rank hold SLN as of Q4 2025.

  • Global Retirement Partners held 1,000 shares of Silence Therapeutics worth $6.08K as of Q4 2025.
  • Silence Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • Silence Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3368 holding.
  • 58 funds tracked by Wall St. Rank held Silence Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.